Chemical synthesis and biological validation of immobilized protein kinase inhibitory Leucettines. - Université de Rennes Accéder directement au contenu
Article Dans Une Revue European Journal of Medicinal Chemistry Année : 2013

Chemical synthesis and biological validation of immobilized protein kinase inhibitory Leucettines.

Résumé

Leucettines, a family of marine sponge-derived 2-aminoimidazolone alkaloids, are potent inhibitors of DYRKs (dual-specificity, tyrosine phosphorylation regulated kinases) and CLKs (cdc2-like kinases). They constitute promising pharmacological leads for the treatment of several diseases, including Alzheimer's disease and Down syndrome. In order to investigate the scope of potential targets of Leucettine L41, a representative member of the chemical class, we designed an affinity chromatography strategy based on agarose-immobilized leucettines. A synthesis protocol for the attachment of a polyethylene (3 or 4 units) linker to L41 was first established. The linker attachment site on L41 was selected on the basis of the co-crystal structure of L41 with several kinases. L41 was then covalently bound to agarose beads through the primary amine located at the end of the linker. Control, kinase inactive Leucettine was also immobilized, as well as free linker devoid of ligand. Extracts of several mouse tissues revealed a complex pattern of interacting proteins, some of which probably resulting from non-specific, hydrophobic binding, while others representing bona fide Leucettine-interacting proteins. DYRK1A and GSK-3 (glycogen synthase kinase-3) were confirmed as interacting targets by Western blotting in various mouse tissues. The Leucettine affinity chromatography resin constitutes a powerful tool to purify and identify the targets of this new promising therapeutic class of molecules.

Dates et versions

hal-00822733 , version 1 (15-05-2013)

Identifiants

Citer

Guillaume Burgy, Tania Tahtouh, Emilie Durieu, Béatrice Foll-Josselin, Emmanuelle Limanton, et al.. Chemical synthesis and biological validation of immobilized protein kinase inhibitory Leucettines.. European Journal of Medicinal Chemistry, 2013, 62, pp.728-37. ⟨10.1016/j.ejmech.2013.01.035⟩. ⟨hal-00822733⟩
121 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More